e-Connect Logo
Issue:  October 2009 •  Archive  •  Subscribe •  Unsubscribe
In This Edition Featured Article Featured CE
•  Editor's Notebook
•  Counseling Pearls
•  It's the Law
•  Clinical Corner
•  Consult Your Pharmacist
•  Educational Spotlight
•  Quick Poll
  Photo Influenza Update: Seasonal and H1N1 Vaccines
All four of the approved H1N1 vaccines are monovalent, while the seasonal influenza vaccine for the 2009-2010 season is a trivalent-inactivated vaccine containing A/Brisbane/59/2007 H1N1-like, A/Brisbane 10/2007 H3N2-like, and B/Brisbane/60/2008-like antigens.
  Photo Ovarian Cancer: One of the Common Gynecologic Malignancies
Pharmacists can play an integral role in the treatment of this disease, historically considered a “silent cancer” because most patients present in the late stages, by understanding chemotherapy treatments and providing appropriate supportive-care options.

Advertisement

Editor's Notebook
Ben Franklin’s Health Care Reform Program

An ounce of prevention really is worth a pound of cure when one realizes that our current system is based on reimbursement for costly medical procedures rather than upfront payment for far less expensive preventive measures.
Counseling Pearls
Photo Updates in Nonprescription Therapy for Heartburn and GERD

Understanding the relative advantages and disadvantages of OTC antacids, H2 antagonists, and proton pump inhibitors used in the treatment of this common gastrointestinal complaint allows the pharmacist to provide lasting relief for patients.
The Dying Patient: Choices, Control, and Communication

Pharmacists should be familiar with the concepts surrounding end-of-life care in order to better serve seniors with recommendations and guidance.
It's the Law
HIPAA Breach Notification Rule

New Federal guidelines address compliance procedures when protected health information is disclosed in an unauthorized manner.
Clinical Corner
Photo New Drug Review 2009

This article reviews five new drugs (rufinamide, lacosamide, iloperidone, milnacipran, febuxostat) that were approved in the past year, including basic clinical and pharmacologic profiles and selected pharmacokinetic, adverse-reaction, drug interaction, and dosing data.
Photo Evidence-Based Medicine in Pharmacy Practice

With pharmacists moving more toward a role of medication therapy management versus dispensing, it is crucial for the practitioner to keep up with the latest guidelines so they may answer clinical questions with accuracy.
 

Advertisement

 
Consult Your Pharmacist
Getting to the Bottom of Common Foot Problems

Patients often request relief for foot discomfort due to a wide range of causes, including corns and calluses.
Educational Spotlight
Perimenopause: Management of Common Symptoms During the Menopausal Transition

Pharmacists should be prepared to discuss the complex health concerns and common treatment options encountered during this stage of a woman’s life.
An Update on the Current Treatment of HIV

The combining of drugs from the six different medication classes used to treat this disease holds promise for many patients.
 

US Pharmacist's Platinum Plus MasterCard Credit Card Carry the US Pharmacist's Platinum Plus® MasterCard credit card!

Carry the only card that helps support our programs and initiatives at no additional cost to you. Simply click here to apply online today.
Newswire
FDA Approves Gardasil for Preventing Genital Warts in Men and Boys
Silver Spring, MD — The FDA approved the vaccine Gardasil for the prevention of genital warts resulting from the human papillomavirus (HPV) types 6 and 11 in boys and men, ages 9 through 26. Each year, about two out of every 1,000 men in the United States are diagnosed with genital warts. Gardasil currently is approved for use in girls and women ages 9 through 26 for the prevention of cervical, vulvar, and vaginal cancer caused by HPV types 16 and 18; precancerous lesions caused by types 6, 11, 16, and 18; and genital warts caused by types 6 and 11. Most genital warts are caused by HPV infection, which is the most common sexually transmitted infection in the U.S.
IMS Predicts 4% to 6% Global Pharma Market Growth in 2010
Norwalk, CT — IMS Health reported that the value of the global pharmaceutical market in 2010 is expected to grow 4% to 6% on a constant-dollar basis, exceeding $825 billion. The forecast predicts global pharmaceutical market sales to grow at a 4% to 7% compound annual rate through 2013, and considers the impact of the global macroeconomy, the changing mix of innovative and mature products, and the rising influence of health care access and funding on market demand. The value of the global pharmaceutical market value is expected to expand to $975+ billion by 2013.
FDA Warns About Illegal H1N1 Vaccines on the Internet
Silver Spring, MD — The FDA warned consumers about purchasing any products over the Internet that claim to diagnose, prevent, treat, or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients. One of the orders, which arrived in an unmarked envelope with a postmark from India, consisted of unlabeled, white tablets taped between two pieces of paper. When analyzed by the FDA, the tablets were found to contain talc and acetaminophen, but none of the active ingredient oseltamivir. The Web site disappeared shortly after the FDA placed the order.
Smoking Bans Reduce Heart Attack Risk
Washington, D.C. — A report from the Institute of Medicine says that smoking bans are effective at reducing the risk of heart attacks and heart disease associated with secondhand smoke. The report also provides evidence that breathing secondhand smoke boosts the risk for heart problems in nonsmokers, adding that there is evidence that relatively brief exposures could lead to a heart attack. About 43% of nonsmoking children and 37% of nonsmoking adults are exposed to secondhand smoke in the U.S., according to public health data.
To subscribe to e-Connect, send your name, address, and email address to us by clicking here. U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.